CGP77116
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CGP77116, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS) [Phase 2]